U.S. market Closed. Opens in 2 hours 36 minutes

NBY | NovaBay Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: AMEX)
Day's Range 0.6760 - 0.7271
52 Week Range 0.3600 - 11.55
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 31,322
Average Volume 2,811,187
Shares Outstanding 4,885,690
Market Cap 3,463,954
Sector Healthcare
Industry Biotechnology
IPO Date 2007-10-26
Valuation
Profitability
Growth
Health
P/E Ratio -0.01
Forward P/E Ratio N/A
EPS -74.61
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 24
Country USA
Website NBY
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
*Chart delayed
Analyzing fundamentals for NBY we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see NBY Fundamentals page.

Watching at NBY technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on NBY Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙